Ken Griffin’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
Other funds holding SLN
SL
Ken Griffin's SLN Position: Q3 2026 in Review
Ken Griffin increased its Silence Therapeutics (SLN) stake by 113% in Q3 2026, buying an estimated $18.2M and bringing the position to 2,825,601 shares worth $30.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2070.
Ken Griffin first reported a position in SLN in Q2 2022 and has held it in 13 quarters since. 92 funds tracked by Wall St. Rank hold SLN as of Q3 2026.
- Ken Griffin held 2,825,601 shares of Silence Therapeutics worth $30.9M as of Q3 2026.
- Ken Griffin bought 1,495,976 Silence Therapeutics shares in Q3 2026, an estimated $18.2M.
- Silence Therapeutics made up ﹤0.01% of Ken Griffin's portfolio in Q3 2026, its #2070 holding.
- Ken Griffin first reported a position in Silence Therapeutics in Q2 2022 and has held it in 13 quarters since.
- 92 funds tracked by Wall St. Rank held Silence Therapeutics as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.